The Journal of Korean Obstetrics and Gynecology (대한한방부인과학회지)

The Society of Korean Medicine Obstetrics and Gynecology (대한한방부인과학회)
권호 표지
DOI QR코드

DOI QR Code

Antioxidant and Neuroprotective Effects of Gamisoyo-san

가미소요산(加味逍遙散)의 항산화효과(抗酸化效果)및 신경세포(神經細胞) 보호효과(保護效果)

  • Lee, Seung-Han (Dept. of Oriental Gynecology, College of Oriental Medicine, Kyung-Hee University) ;
  • Lee, Jin-Moo (Dept. of Oriental Gynecology, College of Oriental Medicine, Kyung-Hee University) ;
  • Cho, Jung-Hoon (Dept. of Oriental Gynecology, College of Oriental Medicine, Kyung-Hee University) ;
  • Lee, Chang-Hoon (Dept. of Oriental Gynecology, College of Oriental Medicine, Kyung-Hee University) ;
  • Jang, Jun-Bock (Dept. of Oriental Gynecology, College of Oriental Medicine, Kyung-Hee University) ;
  • Lee, Kyung-Sub (Dept. of Oriental Gynecology, College of Oriental Medicine, Kyung-Hee University)
  • 이성한 (경희대학교 한의과대학 한방부인과 교실) ;
  • 이진무 (경희대학교 한의과대학 한방부인과 교실) ;
  • 조정훈 (경희대학교 한의과대학 한방부인과 교실) ;
  • 이창훈 (경희대학교 한의과대학 한방부인과 교실) ;
  • 장준복 (경희대학교 한의과대학 한방부인과 교실) ;
  • 이경섭 (경희대학교 한의과대학 한방부인과 교실)
  • Received : 2010.07.30
  • Accepted : 2010.08.10
  • Published : 2010.08.31
Download PDF
⟨ Previous Next ⟩

Abstract

Purpose: These studies were undertaken to evaluate the anti-oxidative and neuroprotective effects of Gamisoyo-san(GMSYS). Materials and Methods: We studied the antioxidant effects of GMSYS by assessing the DPPH free radical and the ABTS radical cation inhibition activities, the total polyphenolic contents(TPC). To evaluate the effects of GMSYS in the human neuroblastoma cells, we measured the cell viabilities in SH-SY5Y cells treated with GMSYS. Then we observed the protective effects of GMSYS against 6-OHDA induced neurotoxicity in SH-SY5Y cells. To confirm the neuroprotective effects of GMSYS in the primary culture of mesencephalic dopaminergic cells, we counted the TH-immunopositive cells and measured the NO and TNF-$\alpha$ after the treatment of GMSYS and 6-OHDA. Results: The DPPH free radical and the ABTS radical cation inhibition activities were increased in a dose dependent manner and the IC50 were $133.60{\mu}g/m{\ell}$ and $106.20{\mu}g/m{\ell}$, respectively. The TPC was 0.78%. There were no differences between the various concentrations of GMSYS and the control in the cell viability of SH-SY5Y cells. The neuroprotective effects of GMSYS were shown in the co-treatment group at the low concentrations of $25{\mu}g/m{\ell}$ and the post-treatment group at all concentrations. After the treatment of GMSYS and 6-OHDA in the primary culture of dopaminergic cells, the TH-immunopositive cells were significantly increased in $0.2{\mu}g/m{\ell}$ of GMSYS than the 6-OHDA group. The NO and TNF-$\alpha$ were significantly decreased in $0.2{\mu}g/m{\ell}$ of GMSYS than the 6-OHDA group. Conclusions: This study shows that GMSYS has the antioxidant and neuroprotective effects, especially in the mesencephalic dopaminergic cells. We suggest that GMSYS could be useful for the treatment of postmenopausal depression related with the degeneration of dopamine neuron.

Keywords

References

  1. Farage MA, Osbom TW, MacLean AB. Cognitive, sensory and emotional changes associated with the menstrual cycle: a review. Arch Gynecol Obstet. 2008;278(4):299-307.
  2. Nelson HD. Menopause. Lancet. 2008; 371(9614):760-70. https://doi.org/10.1016/S0140-6736(08)60346-3
  3. Steinberg EM et al. A cross-sectional evaluation of perimenopausal depression. J Clin Psychiatry. 2008;69(6):973-80. https://doi.org/10.4088/JCP.v69n0614
  4. Craig MC, Murphy DG. Estrogen: effects on normal brain function and neuropsychiatric disorders. Climacteric. 2007;10:97-104.
  5. Watson CS et al. Estradiol effects on the dopamine transporter-protein levels, subcellular location and function. J Mol Signal. 2006;1:1-14. https://doi.org/10.1186/1750-2187-1-1
  6. Gardiner SA et al. Pilot study on the effect of estrogen replacement therapy on brain dopamine transporter availability in healthy, postmenopausal women. Am J Geriatr Psychiatry. 2004;12(6) :621-30. https://doi.org/10.1097/00019442-200411000-00008
  7. Craig MC et al. Effect of long-term estrogen therapy on dopaminergic responsivity in post-menopausal women: a preliminary study. Psychoneuroendocrinology. 2004; 29(10):1309-16. https://doi.org/10.1016/j.psyneuen.2004.03.008
  8. 陳師文등. 太平惠民和劑局方. 中國:人民衛生出版社. 1985:308.
  9. 薛己注. 校注婦人良方. 中國:江西人民出版社. 1991:419-23.
  10. 金在瑩, 柳同烈. 丹梔逍遙散에 關한 文獻的考察. 大田大學校韓醫學硏究所 論文集. 1999;7(2):531-51.
  11. 李錫駿, 柳熙英. 柳氏逍遙散과 柳氏歸脾湯의 抗스트레스 效果에 關한 臨床 的硏究. 東醫神經精神科學會誌. 1994;5(1):41-60.
  12. 崔銀洙, 李仁仙. 逍遙散.加味逍遙散의 效能에 關한 實驗的硏究. 大韓韓方婦人科學會誌. 1996;9(1):41-53.
  13. 홍성은 등. 逍遙散이 생쥐에 immobilization stress 負荷後血中免疫機能에 미치는 影響. 大韓韓方婦人科學會誌. 2003;16(3)101-27.
  14. 황귀서, 이기선, 박종형. 단치소요산이 구속 스트레스를 가한 흰쥐의 뇌내 catecholamine 함량변화에 미치는 영향. Kor J Environ Toxicol. 1998;13(3-4) :143-9.
  15. 이정호, 정대규. 逍遙散과 淸肝逍遙散이 스트레스 생쥐의 腦部位別monoamines 含量에 미치는 影響. 東醫神經精神科學會誌. 1998;9(2):1-18.
  16. 金潤相등. 逍遙散이 卵巢摘出흰쥐에 미치는 抗憂鬱效果. 大韓韓方婦人科 學會誌. 2001;14(2);69-84.
  17. 오승희 등. 逍遙散藥鍼이 卵巢摘出흰쥐의 抗스트레스 作用에 미치는 影響. 大韓鍼灸學會誌. 2002;22(1):117-30.
  18. 대한민국 통계청. 2005년 생명표. 2006.
  19. 대한민국 통계청. 2001년 국민건강 . 영양조사. 2002.
  20. Berg JA, Larson CA, Pasvogel AE. Menopausal symptom perception and severity: results from a screening questionnaire. J Clin Nurs. 2008; 17(7):940-8. https://doi.org/10.1111/j.1365-2702.2007.02112.x
  21. Woods NF, Mitchell ES. Pathways to depressed mood for midlife women: observations from the Seattle Midlife Women's Health Study. Res Nurs Health. 1997;29(2):119-29.
  22. Avis NE et al. Longitudinal study of hormone levels and depression among women transitioning through menopause. Climacteric. 2001;4(3) :243-9. https://doi.org/10.1080/cmt.4.3.243.249
  23. Bromberger JT et al. Psychologic distress and natural menopause: a multiethnic community study. Am J Public Health. 2001;91(9):1435-42. https://doi.org/10.2105/AJPH.91.9.1435
  24. Dennerstein L, Soares CN. The unique challenges of managing depression in mid-life women. World Psychiatry. 2008;7(3):137-42. https://doi.org/10.1002/j.2051-5545.2008.tb00180.x
  25. Pae CU et al. Effectiveness of antidepressant treatments in premenopausal versus post-menopausal women: a pilot study on differential effects of sex hormones on antidepressant effects. Biomed Pharmacother. 2008; 30:1-8.
  26. Ng F et al. Oxidative stress in psychiatric disorders: evidence base and therapeutic implications. Int J Neuropsychopharmacol. 2008;11(6):851-76.
  27. Reynolds A et al. Oxidative stress and the pathogenesis of neurodegenerative disorders. Int Rev Neurobiol. 2007 ;82:297-325. https://doi.org/10.1016/S0074-7742(07)82016-2
  28. Gredilla R et al. Differential agerelated changes in mitochondrial DNA repair activities in mouse brain regions. Neurobiol Aging. 2008;11 :1-10.
  29. 中山醫學院. 中醫方劑學選講. 廣州:廣東科學技術出版社. 1983:173-81.
  30. 趙漢栢. 婦人科에 活用되고 있는 逍遙散에 對한 硏究. 大韓韓方婦人科學會誌. 2000;13(2):265-77.
  31. 崔昇勳, 李學仁. 丹梔逍遙散이 白鼠의 甲狀腺損傷에 미치는 影響. 대전대학교 대학원.
  32. 金昭延, 裵鍾局. 加味逍遙散이 스트레스로 因한 白鼠의 乳汁過多分泌에 미치는 影響. 경산대학교 대학원.
  33. 강솔, 김철원. 逍遙散이 白鼠의 排卵에 미치는 影響. 大韓韓方婦人科學會誌. 2000;13(1):111-26.
  34. 박찬수, 손영주. 加味逍遙散이 卵巢摘出로 誘發된 흰 쥐의 骨多孔症에 미치는 影響. 大韓韓方婦人科學會誌. 2008;21(1):1-15.
  35. 김은섭 등. 逍遙散加減化裁의 멜라닌 생성억제와 작용기전에 관한 연구. 大韓韓方婦人科學會誌. 2008;21(1):83-98.
  36. 신경숙 등. 丹梔逍遙散이 갱년기 장애에 미치는 효능에 관한 임상보고. 大韓韓方婦人科學會誌. 2003;16(4):77-82.
  37. Nishizawa M et al. Non-reductive scavenging of 1,1-Diphenyl-2- picrylhydrazyl(DPPH) by peroxyradical: a useful method for quantitative analysis of peroxyradical. Chem Pharm Bull. 2005;53(6):714-6. https://doi.org/10.1248/cpb.53.714
  38. Kim HJ et al. Vanillic acid glycoside and quinic acid derivatives from Gradeniae Fructus. J Nat Prod. 2006 ;69(4):600-3. https://doi.org/10.1021/np050447r
  39. Masuda Y et al. Antioxidant properties of gingerol related compounds from ginger. Biofactors. 2004;21(1-4):293-6. https://doi.org/10.1002/biof.552210157
  40. Sroka Z, Fecka I, Cisowski W. Antiradical and anti-H202 properties of polyphenolic compounds from and aqueous peppermint extract. Z Naturforshc. 2005;60(11-12):826-32.
  41. Kang TH, Baek HY, Kim YC. Protective effect of jakyak-gamcho-tang extract and its constituents against t-BHP -induced oxidative damage in HT22 cells. Am J Chin Med. 2005;33(2) :181-9. https://doi.org/10.1142/S0192415X05002850
  42. Re R et al. Antioxidant activity applying an improved ABTS radical cation decolorization assay. Free Radic Biol Med. 1999;26(9-10):1231-7. https://doi.org/10.1016/S0891-5849(98)00315-3
  43. Appel H et al. Limitations of Folin assays of foliar phenolics in ecological studies. J Chem Ecol. 2001;27(4) :761-78. https://doi.org/10.1023/A:1010306103643
  44. Gomez-Lazaro Met al. 6-hydroxydopamine (6-OHDA) induces Drp-1-dependent mitochondrial fragmentation in SHSY5Y cells. Free Radic Biol Med. 2008;44(11):1960-9. https://doi.org/10.1016/j.freeradbiomed.2008.03.009
  45. Carvour M et al. Chronic low-dose oxidative stress induces caspase-3- dependent $PKC{\delta}$ proteolytic activation and apoptosis in a cell culture model of dopaminergic neurodegeneration. Ann N Y Acad Sci. 2008;1139:197-205. https://doi.org/10.1196/annals.1432.020
  46. Kumral A et al. Neuroprotective effect of the peptides ADNF-9 and NAP on hypoxic-ischemic brain injury in neonatal rats. Brain Res. 2006;1115(1):169-78. https://doi.org/10.1016/j.brainres.2006.07.114
  47. O'Callaghan JP, Sriram K, Miller DB. Defining "neuroinflammation". Ann NY Acad Sci. 2008;1139:318-30.